UK markets close in 24 minutes

Sinopharm Group Co. Ltd. (X2S.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
2.0350-0.0050 (-0.25%)
As of 03:35PM CET. Market open.
Currency in EUR

Valuation measures4

Market cap (intra-day) 5.93B
Enterprise value 13.20B
Trailing P/E 5.50
Forward P/E 7.25
PEG ratio (5-yr expected) 50.46
Price/sales (ttm)0.09
Price/book (mrq)0.75
Enterprise value/revenue 0.03
Enterprise value/EBITDA 0.54

Trading information

Stock price history

Beta (5Y monthly) 0.80
52-week change 3-1.92%
S&P500 52-week change 322.74%
52-week high 32.9590
52-week low 31.8285
50-day moving average 31.9567
200-day moving average 32.2790

Share statistics

Avg vol (3-month) 36.04k
Avg vol (10-day) 32.03k
Shares outstanding 51.34B
Implied shares outstanding 63.12B
Float 81.34B
% held by insiders 10.02%
% held by institutions 153.64%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.09
Forward annual dividend yield 44.59%
Trailing annual dividend rate 30.69
Trailing annual dividend yield 333.82%
5-year average dividend yield 42.59
Payout ratio 427.63%
Dividend date 3N/A
Ex-dividend date 415 Jun 2021
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in CNY.

Fiscal year

Fiscal year ends 31 Dec 2020
Most-recent quarter (mrq)30 Sept 2021

Profitability

Profit margin 1.55%
Operating margin (ttm)4.00%

Management effectiveness

Return on assets (ttm)3.78%
Return on equity (ttm)14.59%

Income statement

Revenue (ttm)510.09B
Revenue per share (ttm)159.03
Quarterly revenue growth (yoy)6.70%
Gross profit (ttm)40.32B
EBITDA 22.46B
Net income avi to common (ttm)7.93B
Diluted EPS (ttm)0.3410
Quarterly earnings growth (yoy)2.70%

Balance sheet

Total cash (mrq)33.15B
Total cash per share (mrq)10.62
Total debt (mrq)77.37B
Total debt/equity (mrq)80.29
Current ratio (mrq)1.29
Book value per share (mrq)19.22

Cash flow statement

Operating cash flow (ttm)6.79B
Levered free cash flow (ttm)-10.23B